BRAF 抗体
(B-Raf proto-oncogene, serine/threonine kinase (BRAF))
This gene encodes a protein belonging to the raf/mil family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERKs signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene are associated with cardiofaciocutaneous syndrome, a disease characterized by heart defects, mental retardation and a distinctive facial appearance. Mutations in this gene have also been associated with various cancers, including non-Hodgkin lymphoma, colorectal cancer, malignant melanoma, thyroid carcinoma, non-small cell lung carcinoma, and adenocarcinoma of lung. A pseudogene, which is located on chromosome X, has been identified for this gene. [provided by RefSeq, Jul 2008].
recommended
recommended
recommended
BRAF 抗体 by 适用
Find BRAF 抗体 for a variety of species such as anti-Human BRAF, anti-Mouse BRAF, anti-Rat BRAF. The species listed below are among those available. Click on a link to go to the corresponding products.
BRAF 抗体 by 抗体来源
Find BRAF 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
BRAF 抗体 by 克隆形成能力
Find available monoclonal or polyclonal BRAF 抗体. Click on a link to go to the corresponding products.
Popular BRAF 抗体
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human, Monkey
Application
WB, IHC, IF, IHC (p), FACS
Validations
- (9)
Cat. No.
ABIN1496951
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Dog, Human, Monkey, Rat
Application
WB, IHC, IF, IHC (p)
Validations
- (8)
Cat. No.
ABIN1496954
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Dog, Human
Application
WB, IHC, IHC (p)
Validations
- (18)
Cat. No.
ABIN1496961
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, PLA
Validations
- (1)
- (4)
Cat. No.
ABIN513800
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Human
Application
ELISA, IHC
Validations
- (4)
- (4)
Cat. No.
ABIN1724658
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, IF, FACS
Validations
- (7)
Cat. No.
ABIN3029542
Quantity
0.4 mL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IHC, ICC
Validations
- (2)
- (3)
Cat. No.
ABIN968991
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, IF
Validations
- (3)
Cat. No.
ABIN4906684
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, ELISA, IHC
Validations
- (3)
Cat. No.
ABIN7000920
Quantity
20 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, FACS
Validations
- (6)
- (2)
Cat. No.
ABIN1881118
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Mouse, Rat
Application
IHC
Validations
- (3)
Cat. No.
ABIN7249766
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA
Validations
- (3)
Cat. No.
ABIN513799
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF
Validations
- (3)
Cat. No.
ABIN513802
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
WB, ELISA, IHC, IF, ICC
Validations
- (3)
Cat. No.
ABIN6256588
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse
Application
WB, ELISA, IHC, IF, ICC
Validations
- (3)
Cat. No.
ABIN6256339
Quantity
100 μL
Datasheet
Datasheet
Latest Publications for our BRAF 抗体
: "Protein expression of KIT, BRAF, GNA11, GNAQ and RASSF1 in feline diffuse iris melanomas." in: Veterinary journal (London, England : 1997), Vol. 249, pp. 33-40, (2019) (PubMed).: "Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma." in: Veterinary ophthalmology, Vol. 19 Suppl 1, pp. 44-55, (2016) (PubMed).
: "HNF4? is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer." in: Gut, (2014) (PubMed).
: "Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma." in: Molecular & cellular proteomics : MCP, Vol. 12, Issue 5, pp. 1335-49, (2013) (PubMed).
: "TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis." in: BMJ open, Vol. 2, Issue 5, (2012) (PubMed).
: "BRAF drives synovial fibroblast transformation in rheumatoid arthritis." in: The Journal of biological chemistry, Vol. 285, Issue 45, pp. 34299-303, (2010) (PubMed).
: "Calcineurin increases glucose activation of ERK1/2 by reversing negative feedback." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Issue 51, pp. 22314-9, (2010) (PubMed).
: "Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, Issue 35, pp. 5705-12, (2008) (PubMed).
: "The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane." in: Endocrine-related cancer, Vol. 13, Issue 1, pp. 257-69, (2006) (PubMed).
: "Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma." in: Annals of surgery, Vol. 244, Issue 5, pp. 799-804, (2006) (PubMed).
Aliases for BRAF 抗体
B-Raf proto-oncogene, serine/threonine kinase (BRAF) 抗体B-Raf proto-oncogene, serine/threonine kinase (Braf) 抗体
B-Raf proto-oncogene, serine/threonine kinase S homeolog (braf.S) 抗体
B-Raf proto-oncogene, serine/threonine kinase (braf) 抗体
Braf transforming gene (Braf) 抗体
si:dkey-222f8.3 (si:dkey-222f8.3) 抗体
9930012E13Rik 抗体
AA120551 抗体
AA387315 抗体
AA473386 抗体
B-Raf 抗体
B-raf 抗体
B-RAF1 抗体
b-raf1 抗体
BRAF 抗体
braf 抗体
Braf-2 抗体
BRAF1 抗体
braf1 抗体
Braf2 抗体
C-RMIL 抗体
C87398 抗体
C230098H17 抗体
D6Ertd631e 抗体
fc48g01 抗体
NS7 抗体
RAFB1 抗体
rafb1 抗体
RMIL 抗体
sierrabraf 抗体
wu:fc48g01 抗体
您还需要查找其他产品吗？
You are here:
